Use of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Statin ‐Associated Immune‐Mediated Necrotizing Myopathy: A Case Series

ConclusionPCSK9 inhibitors are safe for long ‐term use as a cholesterol‐lowering agent in patients with statin‐associated IMNM.

Source: Arthritis and Rheumatology - August 5, 2019 Category: Rheumatology Authors: Eleni Tiniakou, Erika Rivera, Andrew L. Mammen, Lisa Christopher ‐Stine Tags: Brief Report Source Type: research